Columbia University Medical Center- New York Presbyterian Dept of Oncology is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Columbia University Medical Center- New York Presbyterian Dept of Oncology has participated in 2 clinical trials.
Therapeutic areas: c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM, Medulloblastoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Columbia University Medical Center- New York Presbyterian Dept of Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia University Medical Center- New York Presbyterian Dept of Oncology has 2 clinical trials on record. Their work covers c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM, Medulloblastoma.
Columbia University Medical Center- New York Presbyterian Dept of Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.